MARPLAN
NDC 72336-032, isocarboxazid, tablet, from Lifsa Drugs LLC.
- Product NDC
- 72336-032
- Status
- Listed
- Labeler
- Lifsa Drugs LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA011961
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72336-032 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ISOCARBOXAZID10 mg/1
Pharmacologic classes
Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72336-032-01 | 72336003201 | 100 TABLET in 1 BOTTLE, PLASTIC (72336-032-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/95fde749-44ad-4668-86c4-0ff17bca0074
Use it
Look up 72336-032 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72336-032 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72336-032. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.